Willingness to accept chemotherapy and attitudes towards costs of cancer treatment; A multisite survey study in the Netherlands
van Dijk, E F M M, Coşkuntürk, M, Zuur, A T, van der Palen, J, van der Graaf, W T A, Timmer-Bonte, J N H, Wymenga, A N M
Published in Netherlands journal of medicine (01.08.2016)
Get full text
Published in Netherlands journal of medicine (01.08.2016)
Journal Article
Ipilimumab with nivolumab in molecularly selected patients with castration-resistant prostate cancer: primary analysis of the phase II INSPIRE trial
van Wilpe, S., Kloots, I.S.H., Slootbeek, P.H.J., den Brok, M., Westdorp, H., Franken, M.D., Coskunturk, M., Osinga, T., Bloemendal, H., Adema, G., Smeenk, R.J., Nagarajah, J., van Ipenburg, J., Kroeze, L.I., Ligtenberg, M.J.L., Schalken, J., Gerritsen, W.R., Mehra, N.
Published in Annals of oncology (16.09.2024)
Published in Annals of oncology (16.09.2024)
Get full text
Journal Article
Preferences for treatments in medical oncology: A multisite, prospective survey study in the Netherlands
Coşkuntürk, M, van Dijk, E, Zuur, A.T, Adang, E.M, Stalmeier, P.F, van der Palen, J.A, Steuten, L.M, Timmer-Bonte, J.N, Wymenga, A.N
Published in Journal of geriatric oncology (01.10.2013)
Published in Journal of geriatric oncology (01.10.2013)
Get full text
Journal Article
LBA72 Nivolumab 3mg/kg and ipilimumab 1mg/kg (nivo3/ipi1) in molecularly selected patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Mehra, N., Van Wilpe, S., Westdorp, H., Kloots, I., Slootbeek, P., Brok, M. den, Franken, M., Coskuntürk, M., Bloemendal, H., Nagarajah, J., van Ipenburg, J., Kroeze, L., Ligtenberg, M., Schalken, J.A., Gerritsen, W.R.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1391P Tumor-first mutation-specific risk approach to trigger germline testing in castration-resistant prostate cancer
Kloots, I.S.H., Kets, M., Schuurs-Hoeijmakers, J., Westdorp, H., Coskunturk, M., Bloemendal, H., Gerritsen, W.R., van Oort, I.M., Ligtenberg, M., Mehra, N.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1388P Interim safety analysis of nivolumab 3mg/kg and ipilimumab 1mg/kg (nivo3/ipi1) in molecular-selected patients (pts) with metastastic castration-resistant prostate cancer (mCRPC)
van Wilpe, S., Westdorp, H., Kloots, I.S.H., Slootbeek, P., den Brok, M., Adema, G., Kerkmeijer, L., Smeenk, R.J., Coskunturk, M., Bloemendal, H., Schalken, J., Erp, N.V., Gerritsen, W.R., Mehra, N.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
Ipilimumab with Nivolumab in molecular-Selected patients with castration-resistant PRostate cancer: primary analysis of the Phase 2 INSPIRE trial
van Wilpe, S, Kloots, I S H, Slootbeek, P H J, Brok, M den, Westdorp, H, Franken, M D, Coskunturk, M, Osinga, T, Bloemendal, H, Adema, G, Smeenk, R J, Nagarajah, J, van Ipenburg, J, Kroeze, L I, Ligtenberg, M J L, Schalken, J, Gerritsen, W R, Mehra, N
Published in Annals of oncology (10.09.2024)
Get full text
Published in Annals of oncology (10.09.2024)
Journal Article
A young man with a skin lesion after chemotherapy
Keijmel, S P, Coskuntürk, M, Michels, M
Published in Nederlands tijdschrift voor geneeskunde (25.06.2020)
Get more information
Published in Nederlands tijdschrift voor geneeskunde (25.06.2020)
Journal Article